Womens Imaging: Page 23

Is semiannual mammo after breast conserving surgery necessary?
By Amerigo Allegretto
Annual mammography with a clinical exam is enough for women who underwent breast-conserving surgery and were treated with neoadjuvant therapy.
March 8, 2024
Breast Mammo
Social determinants of health influence breast cancer screening uptake
By Amerigo Allegretto
Socioeconomic factors from social determinants of health can influence adherence to breast cancer screening.
March 5, 2024
Mammogram Calendar 400
ECR: What makes small ovarian lesions light up like a lightbulb?
By Liz Carey
Research continues into the value of diffusion-weighted MRI for ovarian cancer treatment planning.
March 4, 2024
Clinical Trial In Radiology
How can radiologists prepare for breast density notification laws?
By Amerigo Allegretto
Lars Grimm, MD, from the Society of Breast Imaging spoke on how breast imaging facilities can best prepare for new breast density notification laws.
February 16, 2024
Screenshot (1072)
Unmet social needs tied to screening mammography use
By Amerigo Allegretto
Women's unmet social needs should be considered to better promote breast cancer screening utilization and early-stage cancer diagnosis.
February 14, 2024
Woman Anxious 400
Low-dose PEM shows promise in breast cancer detection
By Amerigo Allegretto
Low-dose positron emission mammography (PEM) can detect invasive breast cancer in a feasible manner.
February 9, 2024
Images obtained in a 50-year-old female patient with a new biopsy-proven malignant lesion in the left breast. (A) Craniocaudal mammogram of the right breast does not show any lesion. (B) The malignant lesion corresponds with a 7-cm irregular and spiculated mass on the left craniocaudal mammogram. Ultrasound-guided core-needle biopsy revealed grade 2 invasive lobular carcinoma. (C) The bilateral positron emission mammographic craniocaudal color image obtained one hour after intravenous injection of 185 MBq of F-18-labeled fluorodeoxyglucose (F-18 FDG) shows a mass with intense uptake in the left breast with known cancer and no abnormal uptake in the right breast. Positron emission mammographic craniocaudal images of the left breast obtained (D) one hour and (E) four hours after intravenous injection of 185 MBq of F-18 FDG show no substantial visual difference in uptake of the known cancer. (F) Axial contrast-enhanced fat-saturated subtracted T1-weighted MR image with maximum intensity projection reconstruction obtained 90 seconds after intravenous injection of 0.1 mmol of gadolinium-based contrast material per kilogram of body weight also shows the enhancing mass corresponding to known malignancy (arrow) and marked bilateral background parenchymal enhancement, with multiple nonspecific foci of enhancement in the contralateral breast. The patient opted for bilateral mastectomy, which confirmed left-sided malignancy and no malignancy in the contralateral breast. Image courtesy of the RSNA,
Researcher speaks on MyChart Mobile tool with AuntMinnie.com
By Amerigo Allegretto
Seetharam Chadalavada, MD, from the University of Cincinnati speaks with AuntMinnie.com on how a human-centered design framework led to the tool's creation.
February 7, 2024
Screenshot (1067)
ChatGPT shows promise for improving breast cancer education materials
By Kate Madden Yee
ChatGPT can simplify responses to questions about breast cancer prevention and screening, researchers have found.
February 5, 2024
Chat Gpt Artificial Intelligence Ai Head
Residents describe use of POCUS for high-risk pregnancies in Nepal
By Amerigo Allegretto
American radiology residents have reported on clinical rotations in Nepal during which they used point-of-care ultrasound (POCUS) with high-risk pregnancies in a recent commentary.
February 1, 2024
Ultrasound 3 D Fetal Head 400
DCE-MRI determines women at high recurrence risk of breast cancer
By Amerigo Allegretto
DCE-MRI can help distinguish women with high recurrence risk of breast cancer from those with low recurrence risk.
January 24, 2024
Examples of quantification of background parenchymal enhancement (BPE) over fibroglandular tissue (FGT) on breast DCE-MRI scans from three patients. Images from left to right are the first postcontrast T1-weighted images, automated segmentation of the right and left breasts (red contours) and semiautomated tumor segmentation (yellow), automated segmentation of FGT (green), and quantification of BPE (purple) over the FGT regions. (A) Images of a 48-year-old woman diagnosed with invasive ductal carcinoma and assigned a low-risk Oncotype DX distant recurrence risk score (score, 13). The BPE measures at 20% cutoff value were ipsilateral absolute BPE within FGT relative to FGT volume (%BPEF/F) of 9.8% and contralateral %BPEF/F of 9.5%. (B) Images of a 60-year-old woman diagnosed with invasive ductal carcinoma and assigned an intermediate-risk Oncotype DX distant recurrence risk score (score, 19). The BPE measures at 20% cutoff value were as follows: ipsilateral %BPEF/F of 13.3% and contralateral %BPEF/F of 14.7%. (C) Images of a 54-year-old woman diagnosed with invasive ductal carcinoma and assigned a high-risk Oncotype DX distant recurrence risk score (score, 30). The BPE measures at 20% cutoff value were as follows: ipsilateral %BPEF/F of 34.1% and contralateral %BPEF/F of 14.5%. Image courtesy of the RSNA.
TVUS-detected endometriosis lowers live birth odds in first fertility treatment
By Amerigo Allegretto
Deep infiltrating endometriosis on transvaginal ultrasound decreases the chance for a live birth in women undergoing their first fertility treatment.
January 22, 2024
Endometriosis 3 D Illustration 400
Deep learning combines breast imaging data to predict cancer prognosis
By Amerigo Allegretto
Deep-learning models could have potential as predictive tools for breast cancer prognosis.
January 19, 2024
Breast Mammo Computer 400
Previous Page
Page 23 of 691
Next Page